IF: 0.957
Cite Score:
1.46
THOMSON REUTERS - SCOPUS

Cloning and Expression of Beta Subunit Gene of Phycocyanin From Spirulina platensis in Escherichia coli

AUTHORS

Zahra Shoja 1 , Hamid Rajabi Memari 2 , * , Mohammd Roayaei Ardakani 3

AUTHORS INFORMATION

1 Biology Department, Jahrom Branch, Islamic Azad University, Jahrom, IR Iran

2 Agronomy and Plant Breeding Department, Faculty of Agriculture, Shahid Chamran University of Ahvaz, Ahvaz, IR Iran

3 Biology Department, Shahid Chamran University of Ahvaz, Ahvaz, IR Iran

ARTICLE INFORMATION

Jundishapur Journal of Microbiology: 8 (8); e17809
Published Online: August 29, 2015
Article Type: Research Article
Received: January 24, 2014
Revised: May 3, 2014
Accepted: June 2, 2014
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: C-Phycocyanin (C-PC) from blue-green algae such as Spirulina has been reported to have various pharmacological characteristics, including anti-inflammatory and anti-tumor activities. Recombinant β-subunit of C-PC (C-PC/β) is an inhibitor of cell proliferation and an inducer of cancer cell apoptosis.

Objectives: Since C-PC/β has a big potential to be used as a promising cancer prevention or therapy agent, the purpose of this study was to clone and express Spirulina platensis cpcB gene in a bacterial expression system. This is a significant step for the production of this compound.

Materials and Methods: The cpcB gene was amplified using specific primers and cloned in a bacterial expression vector, namely pET43.1a+. Gene expression of cpcB was analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and the dot blotting technique.

Results: The SDS-PAGE analysis and dot blotting confirmed the production of recombinant C-PC/β in the bacterial expression system. Over-expression of cpcB gene was optimized in induction by 1 mM Isopropyl-β-D-Thiogalactoside (IPTG), after four hours of inoculation at 30°C.

Conclusions: Over-expression of the synthetic CPC/β protein in the bacterial system (Escherichia coli BL-21) showed that E. coli can be used as a basis for further research to produce this desired protein in large quantities.

Keywords

Recombinant Proteins Phycocyanin Spirulina

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background

Spirulina platensis is a spiral-shaped, multicellular filamentous cyanobacteria (1). This microalgae is a rich source of minerals, vitamins, unsaturated fatty-acids and proteins; therefore, it is used as a dietary supplement for both animals and humans (2). Up to 50% of Spirulina total proteins are phycobiliproteins (PBPs), a family of light-harvesting proteins (3). PBPs are water soluble proteins, tightly associated αβ heterodimers in which each subunit carries bilin (s) thioether-linked to particular cysteinyl residues (4). These proteins are classified into four classes based on their spectrum properties: allophycocyanin, phycoerythrin, phycoerythrocyanin and phycocyanin (5, 6).

C-phycocyanin (C-PC) is a major light-harvesting biliprotein in S. platensis and is produced in substantial amounts in the cell; at levels up to 20% of the total protein (7). C-phycocyanin of Spirulina, a natural blue protein, has potential application in food and cosmetic coloring (8). Its antioxidant, anti-inflammatory (9, 10), radical scavenging (11) and hepatoprotective (12) properties gives it a spectrum of pharmaceutical applications. Previous studies have demonstrated that C-PC of Spirulina has an anti-tumor activity by inducing apoptosis. In fact, C-PC induces apoptosis by promoting changes in the Bcl-2/Bax ratio, releasing cytochrome c from mitochondria to the cytosol and the cleavage of Poly (ADP) Ribose Polymerase (PARP), which contributes an important mechanism for apoptosis (13-15). Furthermore, in recent studies, it has been demonstrated that recombinant C-PC/β is also an inhibitor of cell proliferation and an inducer of cancer cell apoptosis by promoting cytoskeleton depolymerization and activating caspase activities, which are associated with the extrinsic cell death pathway (16).

The function of the β-subunit is different from that of the whole C-PC protein and it seems that the C-PCβ may be more effective in inhibition of cell proliferation and apoptosis induction than α/βC-PC. The C-PC/β also shows a greater effect on metastatic cancer cells compared to non-metastatic cancer cells. This property may indicate the potential application of C-PC/β as a cancer prevention and/or treatment agent and its use for preventing tumor metastasis (16). Expression of C-PC in bacteria reduces the cost and time for protein production, and the recombinant protein could be further developed to obtain a more efficient protein for therapeutic purposes. Among the systems available for heterologous protein production, Escherichia coli expression systems have been preferred as an option for producing many recombinant proteins (17-20). Escherichia coli facilitates protein expression by its relatively simple, inexpensive and fast high-density cultivation, and its well-known genetics and large number of compatible tools available for biotechnology (21). In this study, E. coli could be an appropriate system for production of C-PC/β, since C-PC/β can be expressed and purified as soluble recombinant protein in E. coli (16). Furthermore high codon usage similarity exists between E. coli and S. platensis (data not shown here), thus codon optimization in E. coli expression system is not required. Therefore, it is attractive to clone and express cpcB gene to generate and purify recombinant proteins in large quantities for pharmaceutical and biomedical purposes.

2. Objectives

The purpose of this study was to clone phycocyanin beta subunit gene of S. platensis in E. coli expression vector. Moreover, expression of recombinant beta subunit of C-PC in E. coli was examined by Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) and immunoblot analysis.

3. Materials and Methods
3.1. Spirulina Culture and Genomic DNA Extraction

Living cyanobacteria, S. platensis, was obtained from a shrimp center at Bushehr. The bacteria were cultured in Zarrouk medium at 30°C. Chemical salts used for preparing Zarrouk medium were obtained from Merk Co. (Germany). The light intensity was 50 μmolm-2s-1 with photoperiod of 12 light/12 dark cycle (22). The filaments were harvested at log phase and the total genomic DNA was extracted using the technique described by Berrendero (23). Briefly, the cells were harvested by centrifugation and resuspended in 400 μL of extraction buffer (100 mM Tris/HCl, pH 8.0, 20 mM ethylenediaminetetraacetic acid (EDTA), 2.5% (w/v) hexadecyltrimethylammonium bromide (CTAB), 1.4 M NaCl, and 0.2% (v/v) 2-mercaptoethanol). Samples were frozen at -70°C and then homogenized in the extraction buffer using a hand-operated homogenizer. Next, samples were incubated at 60°C for 30 minutes, followed by three extractions with chloroform. Supernatant phases were placed in new tubes to which an equal volume of 2-propanol was added, and were then frozen at -20°C for one hour. The samples were centrifuged and the pellet was resuspended in 400 μL of sterile water and the DNA was precipitated again by addition of 0.1 volume of 3 M sodium acetate and two volumes of ethanol and resolved in 20 μL of sterile water, and stored at -20°C (23).

3.2. Primer Design and Polymerase Chain Reaction

The published gene sequence of the cpcB of S. platensis with a size of 519 bp was obtained from www.pubmed.com (accession No. AY804216). The designed primers according to the gene sequences of cpcB were: forward primer 5’-ACTGTGTACATATGTTTGATGC CTTCACCAAGGTGTTTC-3’ (With NdeI site underlined) and reverse primer: 5’-ATATATATGCGGCCGCGGAAACTGCAGCACATGCACGATC-3’ (With NotI site underlined). At the C-terminus, the stop codon was eliminated and replaced with a NotI restriction site so that the expressed C-PC/β would bind to herpes simplex virus (HSV) epitope tag and 6 × His-tag.

Polymerase chain reaction (PCR) was carried out with a thermal cycler (BioRad) using amplicycle reagents in the presence of 100 ng of extracted template DNA, 1.5 mM MgCl2, 0.2 mM dNTP, 1.5 U Taq DNA Polymerase, 2.5 μL of 10 × PCR buffer (All from Cinagen, Iran) and 0.4 μM of each primer (Takapouzist Co, Iran). Reaction conditions included an initial cycle of denaturation at 94°C for five minutes, followed by 35 cycles of denaturation at 94°C for 30 seconds, annealing at 57.6°C for 30 seconds and extension at 72°C for 35 seconds. The resulting PCR product was extended for a further 10 minutes at 72°C. The PCR products were analyzed on 1% agarose gel (Cinagen, Iran) stained with 0.5 μg/mL ethidium bromide (24).

3.3. Construction of the Expression Vector

The pET43.1a+ (Novagen, USA) and PCR product were digested with NdeI and NotI restriction enzymes according to the manufacture’s protocol. The digested fragments were electrophoresed in 0.7% agarose gel and purified from the gel using the gel extraction kit (BIONEER). The purified cpcB gene and the pET43.1a+ vector were ligated using T4 DNA Ligase (TAKARA) at 16°C, overnight. Ligation mixtures were transformed to E. coli DH5α (Novagen, USA) by the CaCl2 method (24) and were selected by plating on LB medium containing 100 μg/mL ampicillin. The obtained colonies from the transformation experiment were used in a colony-PCR assay using specific primers. Next, the plasmids of positive colonies from the PCR-screening experiment were digested with the same enzymes used for cloning. The recombinant strains were selected and confirmed by sequencing.

3.4. Expression of the Recombinant Protein

The pET43.1a+ expression vector containing phycocyanin beta subunit gene, was transformed to E. coli BL21 (DE3) expression host (Novagen, USA) using the CaCl2 transformation method (24). A recombinant strain colony containing cpcB gene was selected to be used in the protein expression experiment, and for comparison with E. coli BL21 (DE3) containing pET43.1a+, as the control, the selected clones were grown at 37°C overnight in Terrific broth (TB) containing 100 μg/mL ampicillin. The cultures inoculated in TB containing the same antibiotic concentration were grown in a shaking incubator at 37°C and 250 rpm. Isopropyl-β-D-thiogalactoside (IPTG) was added in a final concentration of 1 mM to cultures with OD 0.4 at wavelength of 600 nm (25). Cultures were shaken at 30°C and 250 rpm for 10 hours. Bacterial samples were collected before induction and after one, two, four, eight and ten hours from induction point and lysed in 2x sample buffer (100 mM Tris-HCL pH 8, 20% glycerol, 4% SDS, 2% 2-mercaptoethanol (2-ME), 0.2% bromophenol blue). Samples were analyzed by 12.5% SDS-PAGE, and protein bands were visualized by staining with Coomassie blue R250. All solutions of SDS-PAGE and staining were prepared according to instructions specified by Roche Applied Science (26).

Next, the samples were transferred to nitrocellulose membrane and immunodot blot analysis was carried out by anti-His6-peroxidase and 3,3’-diaminobenzidine (DAB) substrate. Solution preparation and the methods were described by Roche Company (the manufacturer of anti-His6 peroxidase). Lysed bacteria were directly spotted onto nitrocellulose membrane. After drying, western blocking solution 1X was added, followed by incubation for one hour at 25°C. The solution was poured out and replaced with anti-His6-peroxidase, followed by incubation for 90 minutes. The solution was poured out and pellet was washed with 1x tris buffered saline tween

strate were added and then the nitrocellulose membrane was washed with washing solution and checked ininduced strain (E.coli containing pET43.1a+ plus cpcB gene), (TBST) for five minutes and this was repeated three times. In the next step, anti-His6-peroxidase and DAB subnon-induced E.coli strain (E.coli containing pET43.1a+ plus cpcB gene) and control strain (E. coli containing pET43.1a+).

4. Results
4.1. Genomic DNA Extraction and Cloning of cpcB Gene

Genomic DNA from the cultured S. platensis cells was extracted (Figure 1) and subjected to PCR amplification. The specific primers amplified a ~ 543 bp fragment (Figure 2). The digested PCR product was then ligated with digested pET43.1a+ vector (with NdeI and NotI) (Figure 3) by T4 DNA ligase. The constructed vector was then transformed to E. coli DH5α, which was selected on the basis of ampicillin resistance. Recombinant plasmid was confirmed by both colony PCR (Figure 4) and enzyme digestion methods followed by sequencing.

Figure 1. Electrophoresis of the Extracted Genome of Spirulina platensis
Electrophoresis of the Extracted Genome of Spirulina platensis

Lane M: GeneRuler™ 1 kb DNA ladder (fermentas); lane 1, 2: extracted genome of S. platensis.

Figure 2. Electrophoresis of Polymerase Chain Reaction on 1% Agarose Gel
Electrophoresis of Polymerase Chain Reaction on 1% Agarose Gel

Lane M: GeneRuler™ 1 kb DNA ladder (fermentas); lane 1: cpcB PCR product.

Figure 3. Double Digestion of pET43.1a+
Double Digestion of pET43.1a+

Lane M: GeneRuler™ 1 kb DNA ladder (fermentas); lane 1: pET43.1a+ (control); Lane 2: double digestion of pET43.1a+ by NdeI and NotI enzyme.

Figure 4. Confirmation of the Presence of cpcB Gene in pET43.1a+ by Colony Polymerase Chain Reaction
Confirmation of the Presence of cpcB Gene in pET43.1a+ by Colony Polymerase Chain Reaction

M: GeneRuler™ 1 kb DNA ladder (fermentas); lanes 1 - 3: randomly selected colonies; lane 4: negative control (colony containing pET43.1a+ without cpcB gene)

Figure 5. Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis Analysis of PC/β Expression
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis Analysis of PC/β Expression

Lane M: protein marker; lane 1, 2: E. coli (BL21) containing pET43.1a+ not induced and induced by IPTG, respectively; Lane 3: cells containing constructed vector not induced; Lane 4 - 8: cells containing constructed vector induced by IPTG for 1, 2, 4, 8 and 10 hours, respectively.

Also, recombinant protein expression was analyzed by immunodot blot. The comparison of the dot blot results confirmed the expression of the C-PC/β protein (Figure 6). The expression of C-PC/β, which has a His tag in the C-terminus and can be detected by anti His tag peroxidase, changed the substrate color, while the proteins from E. coli BL2 (DE3) containing pET43.1a+ did not show any change of color in the dot blot assay.

Figure 6. Dot Blot Analysis of C-PC/β Expression
Dot Blot Analysis of C-PC/β Expression

Dot 1: E. coli BL21 (DE3) containing pET43.1a+; Dot 2: non-induced recombinant strain containing pET43.1a+plus cpcB gene; Dot 3: induced recombinant strain containing pET43.1a+ plus cpcB gene.

5. Discussion

For more than 150 years, PBPs, which are antennae-protein pigments involved in light harvesting, have been extensively studied. Researchers are still fascinated by some noticeable properties of PBPs, such as their structure, fitting to harvest and transfer of light energy to the photosynthetic reaction centers, and will certainly continue for a long time to hold captivating interest for mankind (6).

The C-PC is one type of PBPs that has gained increasing attention owing to its various biological and pharmacological properties. This protein has been shown to be hepatoprotective, antioxidant, radical scavenger, antiarthritic and anti-inflammatory in both in vitro and in vivo experimental models (5, 27). Therefore, much research has been conducted to clone and express the genes encoding phycobiliproteins in bacteria. Recombinant C-PC/α- and β-subunits have been expressed in E. coli (16, 28). For instance, Wang et al. biosynthesized phycocyanin beta subunit from Anabaena, using pGEX-2T vector with the Tac promoter. They found that the recombinant C-PC/β has anti-cancer properties (16). Also, apo-allophycocyanin has been expressed in E. coli using pMALTM-p2X under the Lac promoter (29, 30). The final product yields in E. coli have reached 0.9 g. L-1 for recombinant apo-C-PC β-subunit (16) and 2.75 g. L-1 for recombinant apo-APC (30). However, the expression vectors, which have been used in these studies contained weaker promoters than some other vectors.

Here, we cloned the phycocyanin beta subunit gene from S. platensis, which was successfully over-expressed in E. coli BL21 strain. Although recombinant phycocyanin or PBPs have been previously expressed in E. coli system, the present study describes the expression of CPC/β of S. platensis in E. coli with a different vector and using some treatments for reaching high product yields. We used pET43.1a+ expression vector, which includes strong and inducible T7 promoter. The T7 RNA polymerase, which was cloned in the pET43.1a+ vector, is five times faster than the E. coli RNA polymerase (21) and causes high levels of expression of cpcB. Also, we replaced the Luria-Bertani (LB) medium by TB medium, which supports a high cell density of E. coli and consequently leads to the highest cell density and the over-expression of recombinant proteins (31). Most recombinant proteins over-expressed in E. coli tend to accumulate in the form of insoluble aggregation and the most common way to improve the solubility of recombinant proteins in E. coli is to reduce the induction temperature (32). In order to obtain soluble proteins, we also optimized the culture conditions by reducing the incubation temperature during protein expression.

In addition, the inserted cpcB gene was positioned upstream and in frame with sequences that encode C-terminal fusion peptides. These sequences include an HSV tag and a polyhistidine tag. The HSV tag is an epitope tag that can be used for labeling, detection and purification of HSV-tagged fusion proteins by ELISA and immunoblotting. The presences of 6 × His tag sequences in the target protein also provide the possibility for convenient purification through anti-histidine tags and an Immobilized Metal Affinity Chromatography (IMAC) procedure. Finally, over-expression of the synthetic beta subunit phycocyanin in a bacterial system (E. coli BL-21) showed that we could produce a large amount of this desired protein in Iran, in the near future.

Footnote
References
1 Cevallos GC, Barron BL, Sánchez JV. Spirulina in Human Nutrition and Health. 2008;
2 Andrade MR, Costa JAV. Mixotrophic cultivation of microalga Spirulina platensis using molasses as organic substrate. Aquaculture. 2007; 264(1): 130-4
3 Nomsawai P, De-Marsac NT, Thomas JC, Tanticharoen M, Cheevadhanarak S. Light regulation of phycobilisome structure and gene expression in Spirulina platensis C1 (Arthrospira sp. PCC 9438). Plant Cell Physiol. 1999; 40(12): 1194-202
4 Tooley AJ, Cai YA, Glazer AN. Biosynthesis of a fluorescent cyanobacterial C-phycocyanin holo-alpha subunit in a heterologous host. Proc Natl Acad Sci U S A. 2001; 98(19): 10560-5[DOI][ PubMed ]
5 Guan X, Qin S, Su Z, Zhao F, Ge B, Li F, et al. Combinational biosynthesis of a fluorescent cyanobacterial holo-alpha-phycocyanin in Escherichia coli by using one expression vector. Appl Biochem Biotechnol. 2007; 142(1): 52-9[ PubMed ]
6 Sekar S, Chandramohan M. Phycobiliproteins as a commodity: trends in applied research, patents and commercialization. J Appl Phycol. 2008; 20(2): 113-36
7 Jeamton W, Dulsawat S, Laoteng K, Tanticharoen M, Cheevadhanarak S. Phycocyanin promoter of Spirulina platensis controlling heterologous expression in cyanobacteria. J Appl Phycol. 2010; 23(1): 83-8[DOI]
8 Silveira ST, Quines LK, Burkert CA, Kalil SJ. Separation of phycocyanin from Spirulina platensis using ion exchange chromatography. Bioprocess Biosyst Eng. 2008; 31(5): 477-82[DOI][ PubMed ]
9 Romay C, Gonzalez R, Ledon N, Remirez D, Rimbau V. C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Curr Protein Pept Sci. 2003; 4(3): 207-16[ PubMed ]
10 Deng R, Chow TJ. Hypolipidemic, antioxidant, and antiinflammatory activities of microalgae Spirulina. Cardiovasc Ther. 2010; 28(4)-45[DOI][ PubMed ]
11 Patel A, Mishra S, Ghosh PK. Antioxidant potential of C-phycocyanin isolated from cyanobacterial species Lyngbya, Phormidium and Spirulina spp. Indian J Biochem Biophys. 2006; 43(1): 25-31[ PubMed ]
12 Vadiraja BB, Gaikwad NW, Madyastha KM. Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicty in rats. Biochem Biophys Res Commun. 1998; 249(2): 428-31[DOI][ PubMed ]
13 Liu Y, Xu L, Cheng N, Lin L, Zhang C. Inhibitory effect of phycocyanin from Spirulina platensis on the growth of human leukemia K562 cells. J Appl Phycol. 2000; 12(2): 125-30[DOI]
14 Pardhasaradhi BV, Ali AM, Kumari AL, Reddanna P, Khar A. Phycocyanin-mediated apoptosis in AK-5 tumor cells involves down-regulation of Bcl-2 and generation of ROS. Mol Cancer Ther. 2003; 2(11): 1165-70[ PubMed ]
15 Subhashini J, Mahipal SV, Reddy MC, Mallikarjuna Reddy M, Rachamallu A, Reddanna P. Molecular mechanisms in C-Phycocyanin induced apoptosis in human chronic myeloid leukemia cell line-K562. Biochem Pharmacol. 2004; 68(3): 453-62[DOI][ PubMed ]
16 Wang H, Liu Y, Gao X, Carter CL, Liu ZR. The recombinant beta subunit of C-phycocyanin inhibits cell proliferation and induces apoptosis. Cancer Lett. 2007; 247(1): 150-8[DOI][ PubMed ]
17 Gholipour A, Moosavian M, Galehdari H, Makvandi M, Memari HR, Alvandi A. Cloning and periplasmic expression of peptidoglycan-associated lipoprotein (PAL) protein of Legionella pneumophila in Escherichia coli. Jundishapur J Microbiol. 2010; 3(1): 1-9
18 Ramanan RN, Tik WB, Memari HR, Azaman SNA, Ling T, Tey BT, et al. Effect of promoter strength and signal sequence on the periplasmic expression of human interferon-a2b in Escherichia coli. Afr J Biotechnol. 2010; 9(3)
19 Morowvat MH, Babaeipour V, Rajabi-Memari H, Vahidi H. Metabolic changes of recombinant Escherichia coli BL21 (DE3) during overexpression of recombinant human interferon beta in HCDC. Int J Biosci. 2014; 4(4): 131-8
20 Morowvat MH, Babaeipour V, Rajabi-Memari H, Vahidi H, Maghsoudi N. Overexpression of Recombinant Human Beta Interferon (rhINF-beta) in Periplasmic Space of Escherichia coli. Iran J Pharm Res. 2014; 13: 151-60[ PubMed ]
21 Sorensen HP, Mortensen KK. Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol. 2005; 115(2): 113-28[DOI][ PubMed ]
22 Raoof B, Kaushik BD, Prasanna R. Formulation of a low-cost medium for mass production of Spirulina. Biomass Bioenergy. 2006; 30(6): 537-42[DOI]
23 Berrendero E, Perona E, Mateo P. Genetic and morphological characterization of Rivularia and Calothrix (Nostocales, Cyanobacteria) from running water. Int J Syst Evol Microbiol. 2008; 58: 447-60[DOI][ PubMed ]
24 Sambrook J, Russel DW. Molecular cloning, a laboratory manual. 2001;
25 Abdolrasouli N, Memari HR, Ardakani MR, Ebrahimi MA, Ebrahimi N. Production of Human Alpha 2b Interferon in E. coli Expression System. Jundishapur Sci Med J. 2013; 12(3): 325-34
26 Lab FAQS - find a quick solution. 2011;
27 Ge B, Qin S, Han L, Lin F, Ren Y. Antioxidant properties of recombinant allophycocyanin expressed in Escherichia coli. J Photochem Photobiol B. 2006; 84(3): 175-80[DOI][ PubMed ]
28 Bryant DA, Dubbs JM, Fields PI, Porter RD, Lorimier R. Expression of phycobiliprotein genes in Escherichia coli. FEMS Microbiol Letters. 1985; 29(3): 343-9[DOI]
29 Ge B, Tang Z, Lin L, Ren Y, Yang Y, Qin S. Pilot-scale fermentation and purification of the recombinant allophycocyanin over-expressed in Escherichia coli. Biotechnol Lett. 2005; 27(11): 783-7[DOI][ PubMed ]
30 Ge B, Tang Z, Zhao F, Ren Y, Yang Y, Qin S. Scale-up of fermentation and purification of recombinant allophycocyanin over-expressed in Escherichia coli. Process Biochem. 2005; 40(10): 3190-5[DOI]
31 Tartof KD, Hobbs CA. Improved media for growing plasmid and cosmid clones. Focus. 1987; 9(2): 12
32 Liu S, Chen H, Qin S, Zhang W, Guan X, Lu Y. Highly soluble and stable recombinant holo-phycocyanin alpha subunit expressed in Escherichia coli. Biochem E J. 2009; 48(1): 58-64[DOI]
COMMENTS

LEAVE A COMMENT HERE: